The Science
The Nutritional Science
Behind PHYBA
A clinical reference document examining the mechanisms of action, evidence grades, pharmacokinetics, and formulation rationale behind every active compound in the PHYBA range. Prepared for use by nutrition scientists, naturopaths, integrative practitioners, dieticians, and evidence-informed clinicians.
Primary Mechanisms of Action
PHYBA formulas operate across six core physiological mechanisms. Understanding these mechanisms — rather than surface-level ingredient lists — is what separates genuinely effective sports nutrition from label decoration.
eNOS Activation & Vascular Function
Citrulline Malate and Pomegranate Extract (punicalagins/ellagic acid) both upregulate endothelial nitric oxide synthase (eNOS), increasing NO bioavailability. Elevated NO drives vasodilation, reduces peripheral vascular resistance, and improves oxygen and nutrient kinetics to skeletal muscle during exercise.
↓
Vasodilation → ↑VO₂ delivery → ↑Endurance
Cortisol Regulation via Adaptogenic HPA Modulation
Ashwagandha (withanolides), Schisandra (schisandrins), and Rhodiola Rosea (rosavins/salidroside) modulate hypothalamic-pituitary-adrenal axis reactivity, reducing baseline cortisol and blunting the cortisol response to acute physical and psychological stressors. Chronic elevated cortisol is catabolic, immunosuppressive, and gut-damaging.
Schisandrins → Adrenal tonic effect → HPA resilience
Mitochondrial Complex I Support & ATP Efficiency
Shilajit's dibenzo-α-pyrones support mitochondrial Complex I (NADH dehydrogenase), improving electron transport chain efficiency. Riboflavin (FAD/FMN) and Niacin (NAD+ precursor) are essential cofactors in the ETC. Schisandra further improves mitochondrial respiration efficiency. Collectively these compounds raise ATP output per unit oxygen consumed.
→ ↑NADH → ↑ATP yield → ↑Aerobic capacity
Leucine-Mediated mTORC1 Activation
L-Leucine is a direct activator of mTORC1 (mechanistic target of rapamycin complex 1) via the Ragulator-Rag GTPase pathway, independently of insulin. Phosphorylation of downstream effectors S6K1 and 4EBP1 initiates ribosomal biogenesis and translational machinery for muscle protein synthesis. The anabolic threshold in adults requires ≥2–3g leucine per meal.
→ p-S6K1 + p-4EBP1 → ↑MPS rate
Dual Buffering: Carnosine (Intracellular) + Bicarbonate (Extracellular)
Beta-Alanine is the rate-limiting precursor to carnosine (β-alanyl-L-histidine), which acts as an intracellular H⁺ buffer during anaerobic glycolysis. Sodium bicarbonate operates extracellularly, maintaining blood pH and enhancing H⁺ efflux from contracting muscle. Used in concert, these compounds provide dual-compartment buffering capacity — a meaningful performance advantage in repeated high-intensity efforts.
NaHCO₃ → ↑Plasma [HCO₃⁻] → ↑H⁺ efflux
Multi-Pathway GABAergic Modulation for Sleep Architecture
Moonbeam's botanical complex works across multiple GABA-related mechanisms: Passionflower (chrysin) as a positive allosteric modulator at GABA-A receptors; Lemon Balm (rosmarinic acid) as a GABA transaminase inhibitor elevating synaptic GABA; Chamomile (apigenin) binding the benzodiazepine site of GABA-A; and Lactobacillus plantarum producing GABA de novo in the gut. Saffron (safranal) additionally inhibits serotonin reuptake, improving the 5-HT → melatonin conversion pathway.
Rosmarinic acid → ↓GABA-T → ↑Synaptic GABA
The Gut as Physiological Foundation
Every PHYBA formula is designed around a gut-first principle — not as a marketing position but as a mechanistic reality. Gut integrity, microbiome diversity, and mucosal immune function are prerequisite conditions for optimal absorption, hormonal balance, immunity, and neurological health.
During sustained aerobic exercise at intensities above 60% VO₂max, splanchnic blood flow is reduced by 60–80% as cardiac output is redistributed to working skeletal muscle[1]. This splanchnic hypoperfusion directly compromises intestinal epithelial integrity, activating heat shock proteins and triggering tight junction protein (claudin-1, occludin, ZO-1) disassembly — increasing intestinal permeability and allowing luminal content translocation into the systemic circulation[2].
The downstream consequences include systemic endotoxaemia (LPS translocation), activation of TLR4-mediated NF-κB inflammatory cascades, elevation of pro-inflammatory cytokines (IL-6, TNF-α), and suppression of mucosal secretory IgA — collectively constituting exercise-induced immune suppression and prolonged systemic inflammation[3]. This is not a marginal phenomenon. It is the primary mechanism of post-exercise immunosuppression in endurance athletes.
PHYBA addresses this at four levels simultaneously: epithelial fuel supply (Tributyrin/Butyrate, L-Glutamine), tight junction protein upregulation (Glutamine, Tributyrin), luminal microbiome fortification (Lactospore®, L. rhamnosus, Akkermansia muciniphila), and systemic anti-inflammatory signalling (adaptogenic polyphenols, fulvic acids).
Gut–Brain Axis
The enteric nervous system contains 500 million neurons and produces 90–95% of the body's serotonin. Psychobiotics (B. longum, L. plantarum) modulate HPA axis reactivity via vagal afferent signalling, reducing cortisol and improving GABA:glutamate ratio — directly impacting sleep quality, stress resilience, and cognitive performance under training load.
Gut–Lung Axis
Bidirectional immunological communication between the gut microbiome and pulmonary immune tissue operates via circulating short-chain fatty acids, immune cell trafficking, and systemic cytokine signalling. Akkermansia muciniphila — the keystone Solarbeam strain — is the species most consistently associated with reduced systemic inflammation and improved mucosal immunity across both compartments.
Gut–Immune Interface
Gut-associated lymphoid tissue (GALT) constitutes approximately 70% of total immune activity. L-Glutamine is the primary fuel for rapidly proliferating lymphocytes and enterocytes. Glutamine depletion during prolonged exercise (plasma levels fall 20–30% post-endurance event) directly impairs GALT function, creating the post-exercise immunosuppression window exploited by respiratory pathogens.
Key Ingredient Deep-Dives
Selected active compounds examined in detail — mechanism, pharmacokinetics, evidence grade, and clinical dosing rationale.
Akkermansia muciniphila occupies a unique position in the microbiome — it is both a mucin-degrading organism and a primary driver of mucus layer renewal. By colonising and metabolising the mucus layer, it continuously stimulates mucin secretion from goblet cells, maintaining mucus layer thickness and integrity as a dynamic process rather than passive maintenance[4].
Its outer membrane protein Amuc_1100 directly interacts with intestinal TLR2 receptors, triggering anti-inflammatory signalling, improving tight junction expression, and activating regulatory T-cell responses. This mechanism is responsible for Akkermansia's observed effects on intestinal permeability reduction independent of colonisation density[5].
Longitudinally, Akkermansia abundance is inversely correlated with metabolic syndrome, obesity, type 2 diabetes, and inflammatory bowel conditions — and is one of the most consistently depleted species in aged populations. Its presence in longevity cohorts (centenarians) across multiple independent studies makes it arguably the single most clinically significant probiotic strain for healthy ageing[6].
Pasteurised (heat-killed) Akkermansia has demonstrated equivalent or superior efficacy to live bacteria in RCTs for metabolic outcomes — suggesting membrane protein activity (particularly Amuc_1100) is the primary active mechanism rather than live colonisation[7].
Citrulline Malate (CM) operates via a dual mechanism that distinguishes it from L-Arginine supplementation for NO production. While oral L-Arginine is substantially catabolised by intestinal and hepatic arginase before reaching systemic circulation, L-Citrulline bypasses first-pass metabolism, is taken up by the kidney, and converted to L-Arginine — achieving superior plasma Arginine elevation despite lower direct Arginine content[8].
The malate component enters the TCA (Krebs) cycle as a direct substrate, supporting aerobic ATP regeneration and acting as an indirect shuttle for ammonia (via the malate-aspartate shuttle), reducing exercise-induced hyperammonaemia — a key contributor to central fatigue[9].
In the landmark Pérez-Guisado & Jakeman RCT (2010), CM at 8g/day produced a 52.92% increase in repetitions to failure compared to placebo, with a 40% reduction in muscle soreness at 24 and 48 hours post-exercise. Effect sizes of this magnitude are rare in sports nutrition research[10].
Butyrate (butyric acid) is the primary energy substrate for colonocytes and intestinal epithelial cells — providing 60–70% of total colonocyte energy requirements. Tributyrin, a pro-drug triglyceride ester, delivers butyrate with superior oral bioavailability compared to sodium butyrate salts, bypassing the taste and odour issues of free butyric acid and achieving more stable intestinal delivery[11].
Beyond its role as an intestinal fuel, butyrate is a potent histone deacetylase (HDAC) inhibitor, modulating epigenetic gene expression in colonocytes and immune cells. This HDAC inhibition drives anti-inflammatory gene expression, promotes intestinal stem cell renewal, supports tight junction protein synthesis, and activates the free fatty acid receptor GPR109a — triggering regulatory T-cell differentiation that suppresses mucosal inflammation[12].
In the context of exercise-induced gut permeability, Tributyrin provides a direct countermeasure: fuelling the enterocytes whose energy supply is compromised by splanchnic hypoperfusion, and simultaneously signalling repair of tight junction proteins disrupted by ischaemia-reperfusion injury. No other single compound addresses exercise-induced gut damage through as many simultaneous mechanisms.
Creatine monohydrate is the most extensively researched ergogenic compound in sports science — over 500 peer-reviewed studies, confirmed safe in clinical use across all age groups from adolescents to elderly populations. Its mechanism is well-characterised: creatine phosphorylation via creatine kinase creates phosphocreatine (PCr), which rapidly rephosphorylates ADP to ATP during high-intensity efforts where oxidative phosphorylation cannot keep pace with demand[13].
Beyond the canonical PCr shuttle, creatine has emerging significance across several non-sport domains: neuroprotection (animal models of Alzheimer's and Parkinson's), bone mineral density maintenance in post-menopausal women, anti-sarcopenic effects in older adults (synergistic with resistance training), and glycogen synthesis enhancement post-exercise (insulin-mediated creatine transport also stimulates GLUT4 translocation)[14].
Clinically, the ISSN Position Stand (2017) categorises creatine monohydrate as Category A evidence — the highest evidence classification — for high-intensity exercise performance. It is explicitly identified as the most effective nutritional ergogenic for this purpose, outperforming every single other compound in the sports nutrition literature on the combined metrics of effect size, study volume, and safety profile.
Evidence Grade Overview
Key clinical studies underpinning PHYBA formulations, graded by study design quality and effect size relevance.
Patented Active Ingredient Rationale
Where ingredient form and manufacturing quality meaningfully affects clinical outcomes, PHYBA uses patented, validated branded ingredients with published dossier data.
| Branded Ingredient | Generic Name | Patent Advantage | Key Published Data | Used In | Grade |
|---|---|---|---|---|---|
| Cluster Dextrin® (HBCD) | Highly Branched Cyclic Dextrin | Osmolality ~12 mOsm/kg vs maltodextrin ~60–80. Rapid gastric emptying without osmotic fluid shift. Validated GI tolerance advantage in exercise conditions. | Suzuki et al., 2014 — ↓RPE, ↓GI symptoms vs maltodextrin at matched CHO dose | Sonic Energy | A |
| DigeZyme® | Multi-enzyme complex (amylase, protease, lipase, cellulase, lactase) | Substrate-specific 5-enzyme blend with published efficacy data across protein digestibility, lactose intolerance, and bloating reduction. Validated stability through supplement processing. | Manufacturer dossier + independent trials on protein digestibility and GI comfort | Gut Guardian, Phyto-Fusion | B |
| Lactospore® (B. coagulans MTCC 5856) | Bacillus coagulans spore-forming probiotic | Spore-forming — survives gastric acid (pH 2), processing temperatures, and shelf life without refrigeration. Germinates in small intestine for genuine microbiome impact. Multiple published RCTs. | RCTs demonstrating ↓IBS symptoms, ↑stool consistency, ↑protein digestibility in plant-protein consumers | Gut Guardian, Phyto-Fusion, Moonbeam | A |
| Cell Charge™ (Fulvic Minerals) | Fulvic acid + humic acid mineral complex | Electron transport enhancement properties increase bioavailability of co-administered micronutrients. Acts as a natural chelator and cellular uptake facilitator. Trace mineral matrix including >70 ionic minerals. | Emerging mechanistic evidence; ethnobotanical use in Ayurveda (Shilajit class) | Athletic Energy, Super Juice | C |
| Fenoprolic™ (Pine Bark) | Oligomeric proanthocyanidins (OPCs) | Standardised OPC extract with documented eNOS activation and antioxidant properties. Validated for circulation, inflammation, and oxidative damage protection. Superior standardisation vs generic pine bark. | Multiple RCTs on endothelial function, inflammatory markers, and oxidative stress | Super Juice | B |
Longevity Mechanisms in the PHYBA Range
Several PHYBA actives operate at the intersection of performance and cellular longevity — mechanisms relevant to any practitioner working with ageing populations, peri-menopausal athletes, or patients with long-term health optimisation goals.
Telomerase Activation — Astragalus (Astragalosides IV)
Astragaloside IV and cycloastragenol, the bioactive saponins of Astragalus membranaceus, are among the few known small molecules capable of activating telomerase reverse transcriptase (hTERT) in human somatic cells[15]. By elongating telomeres — the protective chromosomal end-caps that shorten with each cell division — these compounds directly address one of the hallmarks of cellular ageing. The commercial compound TA-65 (a concentrated cycloastragenol) demonstrated telomere lengthening in a human clinical trial (Harley et al., 2011), validating the mechanism at relevant doses.
Mitophagy & Mitochondrial Renewal — Urolithin A (Pomegranate)
Pomegranate polyphenols (punicalagins and ellagitannins) are converted by specific gut microbiota to Urolithin A — a compound that activates mitophagy, the selective autophagy of damaged mitochondria. Urolithin A is the only known compound to clinically activate mitophagy in skeletal muscle in human trials, improving mitochondrial function in older adults in a way that exercise alone cannot achieve[16]. This is not a theoretical longevity mechanism — it was demonstrated in a published RCT (Andreux et al., 2019, Nature Metabolism). The individual's capacity to produce Urolithin A depends on microbiome composition, making probiotic co-formulation directly relevant to urolithin bioavailability.
Carnosine, Anti-Glycation & Protein Protection — Beta-Alanine
Beyond its acid-buffering role, muscle carnosine is a potent anti-glycation agent — inhibiting advanced glycation endproduct (AGE) formation by competing with protein lysine residues for carbonyl group binding[17]. Given that glycation is a primary driver of tissue ageing (cross-linking of collagen, lens proteins, and vascular elastin), maintaining high carnosine levels via Beta-Alanine supplementation offers a cellular protection benefit that extends well beyond athletic performance. Muscle carnosine also declines significantly with age, and post-menopausal women show particularly rapid depletion.
Glutathione Synthesis — L-Glutamine
Glutathione (γ-L-glutamyl-L-cysteinyl-glycine) is the primary endogenous antioxidant — central to reactive oxygen species neutralisation, xenobiotic detoxification, and DNA repair. Glutamine is a rate-limiting precursor for glutathione synthesis. Glutathione production declines with age, and glutamine depletion under training stress further limits its synthesis. Supplemental L-Glutamine directly supports ongoing glutathione production, with measurable clinical relevance in athletes and ageing populations alike[18].
"The convergence of microbiome science, mitochondrial biology, and adaptogenic pharmacology in the PHYBA formulation approach represents a genuinely sophisticated model of nutritional intervention — one that is scientifically coherent rather than commercially assembled. The inclusion of Akkermansia muciniphila, Urolithin A precursors, telomerase-activating saponins, and psychobiotics in a sports nutrition context reflects an understanding of health and performance that extends well beyond the conventional pre-workout category."
Formulation Philosophy
The principles that govern every PHYBA formulation decision — and how they differ from industry standard practice.
Mechanism-First Selection
Every ingredient is selected on the basis of its specific mechanism of action and evidence quality — not trending status, cost, or label appeal. The question asked of every candidate compound is: what specific biological pathway does this target, at what dose, and what is the quality of the evidence? Ingredients that cannot pass this test are excluded regardless of market popularity.
Clinical Dose Commitment
Every active is present at a dose with clinical or mechanistic relevance — never at a cosmetic "fairy dust" dose included purely to place an ingredient on the label. This commitment to effective dosing is the primary cost driver in PHYBA formulation and the primary reason PHYBA products deliver measurable outcomes rather than placebo-adjacent effects.
Gut-First Design Principle
Every PHYBA formula considers gut health as a prerequisite condition. This is not a marketing position — it is a systems-biology recognition that nutrient absorption, immune function, hormonal balance, sleep quality, and cognitive performance are all downstream of gut integrity. Formulas that damage or ignore the gut undermine their own efficacy.
Systems Over Silos
Each PHYBA product is designed to function within a complementary ecosystem rather than in isolation. Ingredients are selected for synergistic potential across the range: the urolithin A conversion from pomegranate polyphenols in Solarbeam is enhanced by the probiotic strains in Gut Guardian. Leucine supplementation for MPS is amplified by the digestive enzyme activity in Phyto-Fusion. Systems thinking, not isolated efficacy.
Practitioner Stacking Guide
Evidence-based product combinations for common clinical presentations and performance objectives.
| Clinical Goal | Primary Products | Mechanistic Rationale | Timing Notes |
|---|---|---|---|
| Gut Lining Repair & IBS Support | Gut Guardian + PHYBA Glutamine | Synbiotic triad (prebiotic + probiotic + enzyme) combined with enterocyte-specific fuel (Glutamine). Addresses microbiome, barrier integrity, enzyme sufficiency, and tight junction proteins simultaneously. | Gut Guardian with meals; Glutamine 5g on waking and pre-sleep on empty stomach |
| Endurance Performance (HYROX / Running) | Athletic Energy + Sonic Energy + PHYBA Creatine | Athletic Energy delivers pre-exercise NO + mitochondrial priming. Sonic Energy provides intra-exercise HBCD fuel + electrolytes + 2g creatine. PHYBA Creatine tops up to maintenance dose. Full metabolic coverage without stimulants. | Athletic Energy 30–60 min pre; Sonic Energy intra-workout; Creatine any time daily |
| Sleep Quality & Recovery Optimisation | Moonbeam + Super Juice | Moonbeam's psychobiotic + adaptogen + GABAergic complex addresses sleep architecture, cortisol, and gut-brain axis overnight. Super Juice's adaptogenic base (Ashwagandha, Rhodiola, Schisandra) supports daytime HPA resilience reducing cortisol load entering sleep window. | Super Juice morning; Moonbeam 30–45 min pre-sleep |
| Muscle Preservation in Older Adults (Anti-Sarcopenic) | Phyto-Fusion + PHYBA Leucine + PHYBA Creatine | Older adults require higher leucine thresholds (3–4g/meal) for MPS activation. Phyto-Fusion provides 23g complete protein with DigeZyme® for absorption. PHYBA Leucine supplements meals to anabolic threshold. Creatine is independently anti-sarcopenic via PCr system and emerging anabolic signalling. | Phyto-Fusion + Leucine with 2–3 meals; Creatine 3–5g daily maintenance |
| Immune Resilience & Respiratory Support | Solarbeam + Gut Guardian + PHYBA Glutamine | Solarbeam targets gut-lung axis via Akkermansia + peppermint + Vitamin C complex. Gut Guardian fortifies microbiome as immune foundation. Glutamine fuels GALT (70% of immune activity). Combined: comprehensive mucosal immunity support. | Solarbeam morning; Gut Guardian with largest meal; Glutamine 5g twice daily |
| High-Intensity Interval / Combat Sport Performance | PHYBA Beta-Alanine + PHYBA Sodium Bicarbonate + PHYBA Creatine | Triple-layer acid buffering: Creatine (PCr resynthesis), Beta-Alanine (intracellular H⁺ buffer via carnosine), Sodium Bicarbonate (extracellular blood pH buffer). Addresses all three energy system constraints in 1–7 minute high-intensity efforts. | Beta-Alanine daily (split dosing); Sodium Bicarb 0.2–0.3g/kg 60–90 min pre; Creatine daily |
References
- Zuhl, M. et al. (2014). Exercise-induced intestinal permeability: the role of hyperthermia and intestinal blood flow. Journal of Physiology, 592(7), 1555–1567.
- Dokladny, K., Zuhl, M.N., & Moseley, P.L. (2016). Intestinal epithelial barrier function and tight junction proteins with heat and exercise. Journal of Applied Physiology, 120(6), 692–701.
- Marchetti, L. et al. (2021). Exercise-induced endotoxemia and leaky gut: mechanisms and mitigation. Sports Medicine, 51(12), 2551–2562.
- Plovier, H. et al. (2017). A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium improves metabolism in obese and diabetic mice. Nature Medicine, 23(1), 107–113.
- Plovier, H. & Cani, P.D. (2017). Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut, 65(3), 426–436.
- Biagi, E. et al. (2016). Gut microbiota and extreme longevity. Current Biology, 26(11), 1480–1485.
- Plovier, H. et al. (2017). Amuc_1100 protein from Akkermansia demonstrates equivalent metabolic effects to live bacteria. Nature Medicine, 23, 107–113.
- Schwedhelm, E. et al. (2008). Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. British Journal of Clinical Pharmacology, 65(1), 51–59.
- Bendahan, D. et al. (2002). Citrulline/malate promotes aerobic energy production in exercising muscle. British Journal of Sports Medicine, 36(4), 282–289.
- Pérez-Guisado, J., & Jakeman, P.M. (2010). Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness. Journal of Strength and Conditioning Research, 24(5), 1215–1222.
- Fang, W. et al. (2019). Tributyrin, a butyrate pro-drug, increases butyrate bioavailability and attenuates inflammatory responses. Nutrients, 11(2), 313.
- Parada Venegas, D. et al. (2019). Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Frontiers in Immunology, 10, 277.
- Lanhers, C. et al. (2017). Creatine supplementation and upper limb strength performance: a systematic review and meta-analysis. Sports Medicine, 47(1), 163–173.
- Rawson, E.S. & Venezia, A.C. (2011). Use of creatine in the elderly and evidence for effects on cognitive function in young and old. Amino Acids, 40(5), 1349–1362.
- Harley, C.B. et al. (2011). A natural product telomerase activator as part of a health maintenance program. Rejuvenation Research, 14(1), 45–56.
- Andreux, P.A. et al. (2019). The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature Metabolism, 1(6), 595–603.
- Boldyrev, A.A., Aldini, G., & Derave, W. (2013). Physiology and pathophysiology of carnosine. Physiological Reviews, 93(4), 1803–1845.
- Cruzat, V. et al. (2018). Glutamine: metabolism and immune function, supplementation and clinical translation. Nutrients, 10(11), 1564.